✦ LIBER ✦

Eligibility 2: A prospective, observational, multicentre study on outcomes of peg-interferon/ribavirin (Peg-IFN/RBV) in chronic hepatitis C (CHC)

✍ Scribed by Vukotic, R.; Gamal, N.; Andreone, P.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P1205 ELIGIBILITY 2: A PROSPECTIVE, OBSE

✍ Vukotic, R.; Gamal, N.; Andreone, P. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 69 KB

PEG-IFN alfa-2a (40kd) (Pegasys) plus am

✍ G. Ideo; A. Attili; G. Ruggiero; A. Craxi; G. Di Perri; A. Mangia; A. Picciotto; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 154 KB

1186 PEG-IFN alfa-2A (40KD) (PEGASYS) pl

✍ IDEO, G; ATTILI, A; BABUDIERI, S; CHIRIANNI, A; CRAXI, A; DIPERRI, G; FRANCAVILL 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB

Treatment of chronic hepatitis C in HIV

✍ A. Cargnel; E. Angeli; A. Mainini; A. Casella; G. Gubertini; R. Giorgi; G. Orlan 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 156 KB

13 A PHASE 2, RANDOMIZED STUDY OF HCV-79

✍ P. Pockros; M. Rodriguez-Torres; S. Villano; E. Maller; M. Chojkier 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 68 KB

1003 A prospective assessment of “a la c

✍ DARONDEL, C; MOUSSALLI, J; THIBAUT, V; NAVEAU, S; SIMON, A; MUNTEANU, M; IMBERTB 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB